Literature DB >> 5430408

Gas chromatographic measurement of levels of fenfluramine and norfenfluramine in human plasma, red cells and urine following therapeutic doses.

D B Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5430408     DOI： 10.1016/s0021-9673(00)93657-4

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  10 in total

1.  Amphetamines, growth hormone and narcolepsy.

Authors:  J D Parkes; A G Debono; P Jenner; J Walters
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

2.  Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration.

Authors:  D B Campbell; P Turner
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

3.  Kinetics of fenfluramine isomers in the rat.

Authors:  S Caccia; G Dagnino; S Garattini; G Guiso; R Madonna; M G Zanini
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

4.  A preliminary study of the effect of norfenfluramine on lipogenesis by human adipose tissue in vitro.

Authors:  M Ashwell
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

Review 5.  In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions.

Authors:  Parthena Martin; Maciej Czerwiński; Pallavi B Limaye; Seema Muranjan; Brian W Ogilvie; Steven Smith; Brooks Boyd
Journal:  Pharmacol Res Perspect       Date:  2022-06

6.  Preliminary assessment of flutiorex, a new anorectic drug, in man.

Authors:  J F Giudicelli; C Richer; A Berdeaux
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 7.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

8.  Pharmacokinetics of fenfluramine enantiomers in man.

Authors:  S Caccia; M Ballabio; P De Ponte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

9.  The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.

Authors:  G Cheymol; J Weissenburger; J M Poirier; C Gellee
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

10.  Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.

Authors:  M Schachter; C D Marsden; J D Parkes; P Jenner; B Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.